- Advertisement -
Saturday, March 25, 2023

Our Partner Conferences

Upcoming Events

CEBioForum 2023

Date: 18 Apr 2023 |

It is one of the most important annual events for the biotechnology community, business people and scientists from the life science sector from Poland and Europe. We have been creating a business environment related to biotechnology for over 20 years. The best way to show your company is to tell its story by yourself.

The Digital Healthcare Innovation Summit (DHIS)

Date: 06-07 Jun 2023 | Venue: Boston, MA

The Digital Healthcare Innovation Summit (DHIS) is an annual gathering of the leading innovators, investors, payers, providers, and policymakers who are revolutionizing healthcare. This conference features candid discussions that explore relevant topics for digital health and business leaders with speakers that draw from their experiences to share insightful and beneficial content that is valuable to all.

AI in Healthcare Summit

Date: 18-19 Oct 2023 | Venue: Boston, MA

Discover advances in AI tools and techniques from the world's leading innovators across industry, academia and the healthcare sector. Learn from the experts in speech & text recognition, neural networks, image classification and machine learning. The summit will showcase the opportunities of advancing methods in AI and ML, and their impact across healthcare & medicine.

Magazines

Latest Insights

Course Director BSc (Hons) Diagnostic Radiography and Imaging

Until relatively recently, vision had been considered an attribute of animates only.  The ImageNet challenge provided a showcase for artificial intelligence (AI) tools for...

Powering Diverse and Inclusive Clinical Trials

The Food and Drug Administration (FDA) will soon require clinical trial sponsors to submit a plan for improving diversity among clinical trial participants. While...

Improving antibiotic use with novel diagnostic technologies: Challenges Ahead

Antibiotics have revolutionized human medicine in the twentieth century. Deadly diseases such as streptococcal pneumonia or gangrene became curable, and also other advances of...

The power of novel excipients in 505(b)(2) products

The FDA 505(b)(2) regulatory pathway for drug approval, which allows applicants to use existing safety data as evidence, continues to grow in popularity. Innovators...

Where Is Pharma Headed in 2023?

Learn 10 disruptive trends shaping the future of life science manufacturing, and how you can adapt to stay on target and ahead of the...